<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Respirol Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">Respirol Case Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2051-3380</journal-id><journal-id journal-id-type="publisher-id">RCR2</journal-id><journal-title-group><journal-title>Respirology Case Reports</journal-title></journal-title-group><issn pub-type="epub">2051-3380</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26839691</article-id><article-id pub-id-type="pmc">4722096</article-id><article-id pub-id-type="doi">10.1002/rcr2.137</article-id><article-id pub-id-type="publisher-id">RCR2137</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Reports</subject></subj-group><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor &#x02013; anakinra</article-title><alt-title alt-title-type="right-running-head">CMV associated <styled-content style="fixed-case">HLH</styled-content></alt-title><alt-title alt-title-type="left-running-head">C. <styled-content style="fixed-case">D</styled-content>ivithotawela <italic>et&#x02009;al</italic>.</alt-title></title-group><contrib-group><contrib id="rcr2137-cr-0001" contrib-type="author" corresp="yes"><name><surname>Divithotawela</surname><given-names>Chandima</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="rcr2137-cr-0002" contrib-type="author"><name><surname>Garrett</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="rcr2137-cr-0003" contrib-type="author"><name><surname>Westall</surname><given-names>Glen</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="rcr2137-cr-0004" contrib-type="author"><name><surname>Bhaskar</surname><given-names>Balu</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="rcr2137-cr-0005" contrib-type="author"><name><surname>Tol</surname><given-names>Maneesha</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="rcr2137-cr-0006" contrib-type="author"><name><surname>Chambers</surname><given-names>Daniel C.</given-names></name><xref ref-type="aff" rid="rcr2137-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="rcr2137-aff-0001"><label><sup>1</sup></label><institution>The Prince Charles Hospital</institution><named-content content-type="city">Brisbane</named-content><named-content content-type="country-part">Queensland</named-content><country country="AU">Australia</country></aff><aff id="rcr2137-aff-0002"><label><sup>2</sup></label><institution>Noosa Hospital ICU</institution><named-content content-type="city">Noosa</named-content><named-content content-type="country-part">Queensland</named-content><country country="AU">Australia</country></aff><aff id="rcr2137-aff-0003"><label><sup>3</sup></label><institution>Alfred Hospital</institution><named-content content-type="city">Melbourne</named-content><named-content content-type="country-part">Victoria</named-content><country country="AU">Australia</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Chandima Divithotawela, The Prince Charles Hospital, Rode Road, Chermside, Queensland 4032, Australia. E&#x02010;mail: <email>divichandima@yahoo.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>11</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2016</year></pub-date><volume>4</volume><issue>1</issue><issue-id pub-id-type="doi">10.1002/rcr2.2016.4.issue-1</issue-id><fpage>4</fpage><lpage>6</lpage><history><date date-type="received"><day>19</day><month>9</month><year>2015</year></date><date date-type="rev-recd"><day>29</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>08</day><month>11</month><year>2015</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 The Asian Pacific Society of Respirology <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2015 The Authors. <italic>Respirology Case Reports</italic> published by John Wiley &#x00026; Sons Ltd on behalf of The Asian Pacific Society of Respirology.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution&#x02010;NonCommercial&#x02010;NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:RCR2-4-04.pdf"/><abstract abstract-type="main"><title>Abstract</title><p>Hemophagocytic lymphohistiocytosis (<styled-content style="fixed-case">HLH</styled-content>) is a rare, frequently under&#x02010;recognized condition associated with multi&#x02010;organ failure and very high mortality. A 44&#x02010;year&#x02010;old woman was admitted with a 4&#x02010;day history of fever, headache, delirium, and dyspnea. She progressed rapidly to type 1 respiratory failure and required intubation and mechanical ventilation. Laboratory tests showed pancytopenia, abnormal liver enzyme levels, elevated triglyceride level, and elevated ferritin level. Bone marrow biopsy showed features of <styled-content style="fixed-case">HLH</styled-content>. Computed tomography scan showed bilateral consolidation. Bronchoalveolar lavage was positive for <italic>cytomegalovirus</italic>. She was treated with ganciclovir, methylprednisolone, broad spectrum antibiotics, and <italic>cytomegalovirus</italic> hyperimmunoglobulin without clinical response. Given the poor prognosis and reports of success in pediatric <styled-content style="fixed-case">HLH</styled-content>, anakinra 100&#x02009;&#x000b5;g subcutaneously daily was commenced. There was rapid defervescence, resolution of delirium, and improvement in gas exchange, leading to complete recovery. This case illustrates successful treatment of <styled-content style="fixed-case">HLH</styled-content> associated with cytomegalovirus pneumonitis with the interleukin 1 inhibitor anakinra.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="rcr2137-kwd-0001">Hemophagocytic lymphohistiocytosis</kwd><kwd id="rcr2137-kwd-0002">inflammation</kwd><kwd id="rcr2137-kwd-0003">pulmonary</kwd><kwd id="rcr2137-kwd-0004">virology</kwd></kwd-group><counts><page-count count="3"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>rcr2137</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.7.5 mode:remove_FC converted:22.01.2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="rcr2137-sec-0001"><title>Introduction</title><p>Hemophagocytic syndrome, also known as hemophagocytic lymphohistiocytosis (HLH), is a rare and life&#x02010;threatening disease that is frequently under&#x02010;recognized in adults and associated with very high mortality despite treatment <xref rid="rcr2137-bib-0001" ref-type="ref">[1]</xref>. The syndrome is characterized by fever, altered mental status, hepatosplenomegaly, cytopenia, liver dysfunction, and hyperferritinemia. Hemophagocytosis is caused by dysregulation of natural killer cells and cytotoxic T cells, which may cause excessive activation of macrophages that ingest multiple hematopoietic elements in the bone marrow.</p><p>HLH may be primary (genetic etiology) or secondary to malignancies, autoimmune disease, or infections (most commonly viral). There have been multiple previous reports of cytomegalovirus (CMV) associated HLH developing in patients with ulcerative colitis receiving azathioprine <xref rid="rcr2137-bib-0002" ref-type="ref">[2]</xref>. We report the successful management of this syndrome with ganciclovir, corticosteroids and the new interleukin 1 inhibitor anakinra.</p></sec><sec id="rcr2137-sec-0002"><title>Case Report</title><p>A 44&#x02010;year&#x02010;old woman was admitted to a regional hospital because of a 4&#x02010;day history of fever, headache, delirium, and dyspnea. She progressed rapidly to type 1 respiratory failure and required intubation and mechanical ventilation. Past medical history was notable for ulcerative colitis that was well&#x02010;controlled with azathioprine (150&#x02009;mg daily) and mesalazine (2.4&#x02009;g, twice daily). Physical examination showed hepatomegaly. Laboratory tests showed pancytopenia (hemoglobin, 84&#x02009;g/L; white blood cell count, 1.3&#x02009;&#x000d7;&#x02009;10<sup>9</sup>/L; platelet count, 71&#x02009;&#x000d7;&#x02009;10<sup>9</sup>/L), abnormal liver enzyme levels (alkaline phosphate, 644&#x02009;U/L; gamma&#x02010;glutamyl transferase, 485&#x02009;U/L; aspartate aminotransferase, 431&#x02009;U/L; alanine aminotransferase, 231&#x02009;U/L), elevated fasting triglyceride level (6.6&#x02009;mmol/L), and elevated ferritin level (7000&#x02009;&#x003bc;g/L). Chest radiography and computed tomography (CT) scan showed bilateral consolidation. Brain CT scan and lumbar puncture were normal. CMV DNA was detected in peripheral blood (titer, 6.8&#x02009;&#x000d7;&#x02009;10<sup>5</sup> copies/mL). CMV DNA was also isolated from the bronchoalveolar lavage, but no other pathogens were isolated. Bone marrow aspirate and biopsy confirmed hemophagocytosis (Fig.&#x02009;<xref rid="rcr2137-fig-0001" ref-type="fig">1</xref>). CMV DNA was detected in the bone marrow. Treatment was started with intravenous (IV) ganciclovir (5&#x02009;mg/kg), IV vancomycin, meropenem, oral doxycyline, oseltamivir, and CMV hyperimmunoglobulin on days 0, 7, and 15. The patient's gas exchange and clinical parameters deteriorated, and she was transferred to our center for consideration of veno&#x02010;venous extra&#x02010;corporeal membrane oxygenation (ECMO) support.</p><fig fig-type="Figure" xml:lang="en" id="rcr2137-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Histology of bone marrow aspirate: macrophage engulfing erythrocytes (<styled-content style="fixed-case">M</styled-content>ay&#x02010;<styled-content style="fixed-case">G</styled-content>r&#x000fc;nwald&#x02010;<styled-content style="fixed-case">G</styled-content>iemsa&#x02009;&#x000d7;&#x02009;100).</p></caption><graphic id="nlm-graphic-3" xlink:href="RCR2-4-04-g001"><alt-text>figure</alt-text><permissions><copyright-holder>2015 The Asian Pacific Society of Respirology</copyright-holder></permissions></graphic></fig><p>The patient's clinical condition continued to deteriorate. She had a tracheotomy and was being ventilated with fraction of inspired oxygen (FiO<sub>2</sub>) 0.8. She was delirious and had ongoing fever and cytopenia. The ganciclovir plasma level was sub&#x02010;therapeutic (0.2&#x02009;mg/L); the dose was increased from 5 to 10&#x02009;mg/kg twice daily, but there was no clinical improvement (Fig.&#x02009;<xref rid="rcr2137-fig-0002" ref-type="fig">2</xref>). Given the poor prognosis and reports of success in pediatric HLH, the IL&#x02010;1 inhibitor anakinra was commenced (100&#x02009;&#x000b5;g subcutaneously daily) 17 days after initial presentation. Within 24&#x02009;h the patient had defervesced and delirium had resolved (Fig.&#x02009;<xref rid="rcr2137-fig-0002" ref-type="fig">2</xref>). The peripheral blood counts gradually improved. Seventy two hours later gas exchange had improved only marginally with persistent pulmonary infiltrates suggestive of organizing pneumonia. Intravenous methylprednisolone, 500&#x02009;mg daily for 3 days, was commenced. The patient has extubated 7 days later and was discharged from hospital in excellent condition 18 days after anakinra was commenced.</p><fig fig-type="Figure" xml:lang="en" id="rcr2137-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Treatment Response to <styled-content style="fixed-case">A</styled-content>nakinra. <styled-content style="fixed-case">F<sub>I</sub>O<sub>2</sub></styled-content>, fraction of inspired oxygen; <styled-content style="fixed-case">PO<sub>2</sub></styled-content>, partial pressure of oxygen; <styled-content style="fixed-case">T</styled-content>emp, temperature.</p></caption><graphic id="nlm-graphic-5" xlink:href="RCR2-4-04-g003"><alt-text>figure</alt-text><permissions><copyright-holder>2015 The Asian Pacific Society of Respirology</copyright-holder></permissions></graphic></fig></sec><sec id="rcr2137-sec-0003"><title>Discussion</title><p>HLH should be suspected in patients who present with fever, delirium, cytopenia, and liver dysfunction. Many cases of HLH are not diagnosed initially, likely contributing to poor outcomes. Since many features of HLH are nonspecific and are seen in common conditions such as sepsis and respiratory failure from multiple causes, it is important that respiratory physicians and intensive care specialists include the diagnosis in the list of differentials <xref rid="rcr2137-bib-0001" ref-type="ref">[1]</xref>. The present patient meets the 2004 Histiocyte Society diagnostic criteria: fever, cytopenia, hypertriglyceridemia, hemophagocytosis in bone marrow, and ferritin level &#x0003e; 500&#x02009;&#x003bc;g/L <xref rid="rcr2137-bib-0003" ref-type="ref">[3]</xref>.</p><p>Viral infection, which is often respiratory, is a common cause of secondary HLH and CMV&#x02010;associated HLH appear to be a particular risk in patients with ulcerative colitis treated with azathioprine <xref rid="rcr2137-bib-0002" ref-type="ref">[2]</xref>. In secondary HLH, it is important to treat the underlying cause <xref rid="rcr2137-bib-0001" ref-type="ref">[1]</xref>. The present case emphasizes the importance of therapeutic drug level monitoring with ganciclovir therapy.</p><p>HLH is characterized by markedly low natural killer and T&#x02010;cell&#x02010;mediated cytotoxicity. Deficient cytotoxicity may cause continuous immune activation with concomitant phagocytosis of bone marrow cells due to proliferation and activation of macrophages <xref rid="rcr2137-bib-0001" ref-type="ref">[1]</xref>. The cytokine storm that occurs during this process may cause a severe inflammatory reaction. This cytokine surge, not the original infection, causes the systemic manifestations of secondary HLH and eventually causes end&#x02010;organ damage and mortality. More than any other cytokine family, the IL&#x02010;1 family of ligands and receptors is associated with the inflammatory response. Recent studies have shown elevated IL&#x02010;1 in patients who have HLH <xref rid="rcr2137-bib-0004" ref-type="ref">[4]</xref>. Although the current treatment of choice is dexamethasone, etoposide, and cyclosporine <xref rid="rcr2137-bib-0003" ref-type="ref">[3]</xref>, the use of these agents is often associated with opportunistic infections and treatment failure with secondary HLH <xref rid="rcr2137-bib-0005" ref-type="ref">[5]</xref>. Several reports of IL&#x02010;1 blockade by anakinra in pediatric HLH leading to rapid recovery [<xref rid="rcr2137-bib-0004" ref-type="ref">4</xref>, <xref rid="rcr2137-bib-0005" ref-type="ref">5</xref>], alongside the poor prognosis in adult HLH using the HLH 2004, and recent knowledge of pathogenesis, led us to recommend anakinra for this adult with CMV related HLH.</p><p>In conclusion, physicians should be familiar with the clinical manifestations of HLH because it is often under&#x02010;recognized. IL&#x02010;1 blockade with anakinra may represent a lifesaving approach to the management of this often fatal condition.</p></sec><sec id="rcr2137-sec-0004"><title>Disclosure Statements</title><p>No conflict of interest declared.</p><p>Appropriate written informed consent was obtained for publication of this case report and accompanying images.</p></sec></body><back><ack id="rcr2137-sec-0005"><title>Acknowledgments</title><p>Nina Raju: Haematologist, The Prince Charles Hospital, Queensland, Australia.</p></ack><ref-list id="rcr2137-bibl-0001"><title>References</title><ref id="rcr2137-bib-0001"><label>1</label><mixed-citation publication-type="journal">
<string-name>
<surname>Wijsman</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Roeters van Lennep</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>von dem Borne</surname>
<given-names>PA</given-names>
</string-name>, et&#x02009;al. <year>2009</year>
<article-title>A diagnostic difficulty: two cases of haemophagocytic syndrome in adults</article-title>. <source>Neth. J. Med.</source>
<volume>67</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">19155545</pub-id></mixed-citation></ref><ref id="rcr2137-bib-0002"><label>2</label><mixed-citation publication-type="journal">
<string-name>
<surname>Kullmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>K&#x000e1;r&#x000e1;sz</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Gartner</surname>
<given-names>B</given-names>
</string-name>, et&#x02009;al. <year>2013</year>
<article-title>Acute cytomegalovirus infection&#x02010;associated hemophagocytic syndrome in a patient treated with azathioprine [in Hungarian]</article-title>. <source>Orv. Hetil.</source>
<volume>154</volume>(<issue>49</issue>):<fpage>1959</fpage>&#x02013;<lpage>1961</lpage>.<pub-id pub-id-type="pmid">24292114</pub-id></mixed-citation></ref><ref id="rcr2137-bib-0003"><label>3</label><mixed-citation publication-type="journal">
<string-name>
<surname>Henter</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Horne</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Aric&#x000f3;</surname>
<given-names>M</given-names>
</string-name>, et&#x02009;al. <year>2007</year>
<article-title>HLH&#x02010;2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis</article-title>. <source>Pediatr. Blood Cancer</source>
<volume>48</volume>(<issue>2</issue>):<fpage>124</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">16937360</pub-id></mixed-citation></ref><ref id="rcr2137-bib-0004"><label>4</label><mixed-citation publication-type="journal">
<string-name>
<surname>Rajasekaran</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kruse</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kovey</surname>
<given-names>K</given-names>
</string-name>, et&#x02009;al. <year>2014</year>
<article-title>Therapeutic role of anakinra, an interleukin&#x02010;1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children</article-title>. <source>Pediatr. Crit. Care Med.</source>
<volume>15</volume>(<issue>5</issue>):<fpage>401</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">24583503</pub-id></mixed-citation></ref><ref id="rcr2137-bib-0005"><label>5</label><mixed-citation publication-type="journal">
<string-name>
<surname>Miettunen</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Narendran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jayanthan</surname>
<given-names>A</given-names>
</string-name>, et&#x02009;al. <year>2011</year>
<article-title>Successful treatment of severe paediatric rheumatic disease&#x02010;associated macrophage activation syndrome with interleukin&#x02010;1 inhibition following conventional immunosuppressive therapy: case series with 12 patients</article-title>. <source>Rheumatology (Oxford)</source>
<volume>50</volume>(<issue>2</issue>):<fpage>417</fpage>&#x02013;<lpage>419</lpage>.<pub-id pub-id-type="pmid">20693540</pub-id></mixed-citation></ref></ref-list></back></article>